Using isolated rat aortic rings perfused with Krebs-Henseleit saline, the vascular effects of angiotensin (1-7) (Ang [1-7]) and its interactions with angiotensin II (Ang II) were investigated.
Ang (1-7) induced endothelium-dependent relaxation and vasodilating effects in preparations precontracted with phenylephrine. Without preconstriction, Ang (1-7) at high doses (10 -6—10-5 M) produced either a significant inhibition of Ang IIinduced vasoconstriction or a non-tachyphylactic vasopressor response. While losartan inhibited the vasoconstriction induced by Ang (1-7), A779 blocked only its relaxation. Unlike losartan, blockade of AT2-receptors with PD 123319 had no effect.
Taking into account the biphasic effects of angiotensin (1-7), we propose that it is one of the active components of the renin-angiotensin system, which is involved as a modulator both in the counter-regulatory actions of Ang II and in the self-regulation of its own vasodilating effects.
Goodfriend TLAngiotensins - a family that grows from within . Hypertension1991;17:139-40.
2.
Bottari SP, De Gasparo M., Steckelings UM, Levens NRAngiotensin II receptor subtypes: characterization, signaling, mechanisms and possible physiological implications. Front Neuroendocrinol1993;14:123-71.
3.
Timmermans PBM, Smith RDAngiotensin IIRezeptoren: Physiologische und pharmakologische Bedeutung in Angiotensin II-Antagonismus. Th. Phillip and R.F. Schäfers (editors)Springer-Verlag Berlin, Heidelberg1996, p 1-29.
4.
Dina R., Jafari M.Angiotensin II-receptor antagonists: an overview. Am J Health-Syst Pharm2000;57:1231-41.
5.
Changaris DG , Porter JL, Miller J., Levy RSDes-leu angiotensin I: biosynthesis and drinking response. Regul Pept1988;20:273-80.
6.
Benter IF, Diz DI, Ferrario CMPressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin (1-7). Hypertension1995;26:1138-44.
7.
Ferrario CM, Chappel MC, Tallant EA, Brosnihan KB, Diz DICounter-regulatory actions of angiotensin (1-7). Hypertension1997;30:535-41.
8.
Schiavone MT , Santos RAS, Brosnihan KB, Khosla MC, Ferrario CMRelease of vasopressin from the rat hypothalamoneurohypophysical system by angiotensin (1-7) heptapeptide . Proc Natl Acad Sci USA1988;85:4095-8.
9.
Donoghue M., Hsieh F.,Baronas E. et al. A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circul Res2000;87:c1-c9.
Santos RAS , Campagnole-Santos MI, Baracho NCV, Fontes MAP et al. Characterization of a new angiotensin antagonist selective for angiotensin (1-7); evidence that the actions of angiotensin (1-7) are mediated by specific angiotensin receptors. Brain Res Bull1994;35:2938.
12.
Tallant EA, Lu X., Weiss RB, Chappell MC, Ferrario CMBovine aortic endothelial cells contain an angiotensin (1-7) receptor . Hypertension1997;29:388-93.
13.
Hilchey SD, Bell-Quilley CPAssociation between the natriuretic action of angiotensin (1-7) and selective stimulation of renal prostaglandin release. Hypertension1995;25:1238-44.
14.
Iyer SN, Yamada K., Diz DI, Ferrario CM, Chappell MCEvidence that prostaglandins mediates the antihypertensive actions of angiotensin (1-7). J Cardiovasc Pharmacol2000; 36:109-17.
15.
Paula RD, Linea CV, Khosla MC, Santos RAS.Angiotensin (1-7) potentiates the hypotensive effect of bradykinin in conscious rats.Hypertension1995;26:1150-9.
16.
Brosnihan KB , Li P., Ferrario CMAngiotensin (1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension1996;27:523-8.
17.
Heitsch H., Brovkowych S., Malinski T., Wiener G.Angiotensin (1-7) stimulated nitric oxide and superoxide release from endothelial cells. Hypertension2001;37:72-6.
18.
Almeida AP, Frabregas BC, Madureira MH, Santos RJS.Angiotensin (1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart. Brazil J Med Biol Res2000;33:709-13.
19.
Li P., Chappell MC, Ferrario MC, Brosnihan KBAngiotensin (1-7) augments bradykinin-induced vasodilatation by competing with ACE and releasing nitric oxide. Hypertension1997; 29:394-400.
Luque M., Martin P., Martell N., Fernandez P., Brosnihan KB, Ferrario CMEffects of captopril related to increased levels of prostacyclin and angiotensin (1-7) in essential hypertension. J Hypertens1996;14:799-805.
22.
Yen le Tran A., Forster Chr.Angiotensin (1-7) and the rat aorta: modulation by the endothelium. J Cardiovasc Pharmacol1997;30:676-81.
23.
Lemos VS, Cortes SF, Silva DM, Campagnole-Santos MJ, Santos RAAngiotensin (1-7) is involved in the endotheliumdependent modulation of phenylephrine-induced contraction in the rat aorta. Brit J Pharmacol2002;135:143-8.
24.
Ferrario CM , Iyer SNAngiotensin (1-7): a bioactive fragment of the renin-angiotensin system.Regul Pept1998 ;78:13-18.
25.
Roks A., van Geel P., Pinto YM, Buikema H., Henning RHAngiotensin (1-7) is a modulator of the human reninangiotensin system . Hypertension1999;34:296-301.
26.
Rowe BP, Saylor DL, Speth RC,Absher DRAngiotensin (17) binding at angiotensin II receptors in the rat brain . Regul Pept1995;56:139-46.
27.
Ueda S., Masumori-Maemoto S.,Ashino K. et al. Angiotensin (1-7) attenuates vasoconstriction evoked by angiotensin II in man.Hypertension2000;35:998-1001.
28.
Mahon JM, Carr RD, Nicol AK, Henderson TVAngiotensin (1-7) is an antagonist at the type I angiotensin II receptor . J Hypertens1994;12:1377-81.
29.
van Rodijnen WF, van Lambalgen TA, van Wijhe MH, Tangelder GJ, Ter Wee PMRenal microvascular actions of angiotensin II fragments. Am J Physiol Renal Physiol2002 ; 283:F86-F92.
